Stockscreener 앱 받기
0.6015
2.83%
-0.0175
시간 외 거래:
.60
-0.0015
-0.25%
전일 마감가:
$0.619
열려 있는:
$0.6247
하루 거래량:
56,004
Relative Volume:
0.33
시가총액:
$11.37M
수익:
$43.86M
순이익/손실:
$-37.43M
주가수익비율:
-0.2982
EPS:
-2.0172
순현금흐름:
$-12.50M
1주 성능:
-1.83%
1개월 성능:
-0.25%
6개월 성능:
-39.36%
1년 성능:
-25.74%
1일 변동 폭
$0.6015
$0.6424
1주일 범위
$0.60
$0.6425
52주 변동 폭
$0.5012
$3.44
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Compare TRIB vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
0.6015 | 11.70M | 43.86M | -37.43M | -12.50M | -2.0172 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2015-10-23 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2015-09-03 | 개시 | Raymond James | Outperform |
| 2015-07-29 | 재확인 | ROTH Capital | Buy |
| 2008-07-22 | 재확인 | Roth Capital | Buy |
| 2008-03-17 | 재확인 | Roth Capital | Buy |
| 2007-12-10 | 재확인 | Roth Capital | Buy |
| 2007-10-26 | 재확인 | Roth Capital | Buy |
모두보기
Trinity Biotech Plc Adr 주식(TRIB)의 최신 뉴스
Trinity Biotech names Jerry Lydon head of North America operations - Investing.com
TRIB Stock Chart | TRINITY BIOTECH PLC-SPON ADR (NASDAQ:TRIB) - ChartMill
Trinity Biotech plc Stock: Navigating Challenges in the Diagnostics Sector Amid Market Volatility - AD HOC NEWS
Trinity Biotech reports clinical study results for prostate test By Investing.com - Investing.com South Africa
Trinity Biotech reports clinical study results for prostate test - Investing.com
Trinity Biotech advances CGM+ device toward pivotal trial - Investing.com
Trinity Biotech secures $25M equity financing facility - Investing.com
Trinity Biotech secures $25M equity financing facility By Investing.com - Investing.com South Africa
Trinity Biotech receives Nasdaq delisting warning notice - Investing.com
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares - GlobeNewswire Inc.
Trinity Biotech receives final approval for HIV test manufacturing shift - Investing.com India
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification By Investing.com - Investing.com South Africa
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification - Investing.com
Trinity Biotech plc (TRIB) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Trinity Biotech plc's (NASDAQ:TRIB) Share Price Boosted 54% But Its Business Prospects Need A Lift Too - Sahm
Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today - Sahm
Dow Gains 100 Points; US Durable Goods Orders Decline In October - Benzinga
TRIB: Revenue declined and losses narrowed in Q2 2025 amid restructuring and funding uncertainty - TradingView — Track All Markets
TRIB: Gross margin rose to 45.2% and Adjusted EBITDA turned positive despite a $5.1m net loss - TradingView — Track All Markets
Trinity Biotech secures $5 million funding, extends credit agreement - Investing.com India
Trinity Biotech stock soars after major HIV test order signals market recovery By Investing.com - Investing.com South Africa
Trinity Biotech stock soars after major HIV test order signals market recovery - Investing.com
Trinity Biotech secures $5 million funding, extends credit agreement By Investing.com - Investing.com South Africa
Trinity Biotech receives 9 million unit order for HIV screening product - Investing.com
Trinity Biotech receives 9 million unit order for HIV screening product By Investing.com - Investing.com South Africa
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system - Investing.com
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system By Investing.com - Investing.com South Africa
Trinity Biotech expands rollout of next-gen HbA1c testing system - Investing.com
Trinity Biotech plc (TRIB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Trinity Biotech receives WHO approval for outsourced HIV test manufacturing - Investing.com
Trinity Biotech (TRIB) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $TRIB - MarketBeat
Why You Need Trinity Biotech Plc ADR (TRIB) On Your Watchlist - fostersleader.com
Top investors say Banco Macro S.A. ADR (BMA) ticks everything they need - Setenews
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested - TipRanks
Trinity Biotech appoints Paul Tivnan to board of directors - Investing.com
Trinity Biotech receives approval for offshore manufacturing of HIV test - Investing.com
Should I buy Trinity Biotech (TRIB) - Zacks Investment Research
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test - Investing.com
Trinity Biotech reports positive results for calibration-free CGM - Investing.com
Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market - Sahm
Trinity Biotech receives WHO approval for offshore HIV test manufacturing - Investing.com
Trinity Biotech Appoints New Interim CFO - Investing.com
India Heart Failure POC & LOC Devices Market Size & Outlook, 2030 - Grand View Research
India Hba1c Testing Devices Market Size & Outlook, 2024-2030 - Grand View Research
Canada Lyme Disease Testing Market Size & Outlook, 2024-2030 - Grand View Research
Saudi Arabia Lyme Disease Testing Market Size & Outlook, 2030 - Grand View Research
India Blood Testing Market Size & Outlook, 2025-2030 - Grand View Research
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
Indonesia Blood Testing Market Size & Outlook, 2025-2030 - Grand View Research
Norway Blood Testing Market Size & Outlook, 2025-2030 - Grand View Research
China Blood Testing Market Size & Outlook, 2025-2030 - Grand View Research
Trinity Biotech Plc Adr (TRIB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.93%
자본화:
|
볼륨(24시간):